The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The FDA is eliminating “unnecessary testing” on animals, according to Commissioner Marty Makary. He joined “Katie Pavlich ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the standard.
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...
This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results